A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from...
24-Nov-2021 1:55 PM EST Add to Favorites
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer...
26-Oct-2021 8:05 AM EDT Add to Favorites
A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant...
20-Oct-2021 4:05 PM EDT Add to Favorites
Antibody-drug conjugate shows impressive activity in patients with non-small cell lung cancer with mutation in HER2 gene
More than half of patients with non-small cell lung cancer (NSCLC) bearing a mutation in the HER2 gene had their tumors stop growing or shrink for an extended time after treatment with a drug that hitches a chemotherapy agent to a highly targeted...
17-Sep-2021 9:00 AM EDT Add to Favorites
Consuming higher amounts of Vitamin D – mainly from dietary sources – may help protect against developing young-onset colorectal cancer or precancerous colon polyps, according to the first study to show such an association.
16-Aug-2021 8:00 AM EDT Add to Favorites
The Intermediate Clinical Endpoints of Cancer of the Prostate (ICECaP) working group, led by Dana-Farber Cancer Institute researchers, is being honored by the American Statistical Association (ASA) with the 2021 Statistical Partnerships Among...
9-Aug-2021 3:05 PM EDT Add to Favorites
Dana-Farber Cancer Institute is launching a new podcast series, titled Unraveled, to explain the science behind some of the most important breakthroughs in cancer research.
2-Aug-2021 8:30 AM EDT Add to Favorites
Dana-Farber Brigham Cancer Center is ranked #4 as a Best Hospital for cancer care by U.S. News and World Report for 2021-22
27-Jul-2021 12:05 AM EDT Add to Favorites
See All News
Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
25-Jan-2021 12:05 PM EST
With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST
11-Nov-2013 5:00 PM EST
National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support
17-Sep-2013 3:00 PM EDT
The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT
24-May-2013 3:00 PM EDT
Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT
The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT